257 related articles for article (PubMed ID: 18460247)
21. Gastroesophageal reflux disease.
Fernández-Fernández FJ
N Engl J Med; 2009 Feb; 360(7):729; author reply 729-30. PubMed ID: 19222130
[No Abstract] [Full Text] [Related]
22. Brunner's adenoma, esophageal reflux and gastric ulcer. A case report.
Cavallaro G; Albanese V; Taranto F; Pustorino S; Baldari S
Chir Ital; 2000; 52(6):703-6. PubMed ID: 11200007
[TBL] [Abstract][Full Text] [Related]
23. Observation of gastric glandular cysts in the corpus mucosa of the stomach under omeprazole treatment.
Stolte M; Bethke B; Seifert E; Armbrecht U; Lütke A; Goldbrunner P; Rabast U
Z Gastroenterol; 1995 Mar; 33(3):146-9. PubMed ID: 7754645
[TBL] [Abstract][Full Text] [Related]
24. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
25. Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor.
Jianu CS; Lange OJ; Viset T; Qvigstad G; Martinsen TC; Fougner R; Kleveland PM; Fossmark R; Hauso Ø; Waldum HL
Scand J Gastroenterol; 2012 Jan; 47(1):64-7. PubMed ID: 22087794
[TBL] [Abstract][Full Text] [Related]
26. GASTRIC FUNDIC GLAND POLYPS: CAN HISTOLOGY BE USEFUL TO PREDICT PROTON PUMP INHIBITORS USE?
Brito HLF; Barros C; Freire MV; Silva Filho MND; Nascimento TV
Arq Gastroenterol; 2018; 55(4):380-384. PubMed ID: 30785522
[TBL] [Abstract][Full Text] [Related]
27. Massive fundic gland polyposis in a patient receiving protracted proton-pump inhibitor medication.
Rubio CA; Befrits R; Osterberg J; Ohd J; Miller ML; Ramel S
Anticancer Res; 2010 Jan; 30(1):261-3. PubMed ID: 20150645
[TBL] [Abstract][Full Text] [Related]
28. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
Weigt J; Kandulski A; Büsch F; Malfertheiner P
Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
[TBL] [Abstract][Full Text] [Related]
29. Histological analysis of fundic gland polyps secondary to PPI therapy.
Fukuda M; Ishigaki H; Sugimoto M; Mukaisho KI; Matsubara A; Ishida H; Moritani S; Itoh Y; Sugihara H; Andoh A; Ogasawara K; Murakami K; Kushima R
Histopathology; 2019 Oct; 75(4):537-545. PubMed ID: 31087669
[TBL] [Abstract][Full Text] [Related]
30. Esophageal acid exposure on proton pump inhibitors in unselected asymptomatic gastroesophageal reflux disease patients.
Grigolon A; Cantù P; Savojardo D; Conte D; Penagini R
J Clin Gastroenterol; 2008 Oct; 42(9):969-73. PubMed ID: 18719508
[TBL] [Abstract][Full Text] [Related]
31. Proton pump inhibitor-associated gastric polyps: a retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics.
Choudhry U; Boyce HW; Coppola D
Am J Clin Pathol; 1998 Nov; 110(5):615-21. PubMed ID: 9802346
[TBL] [Abstract][Full Text] [Related]
32. Weakly acidic reflux.
Tack J; Blondeau K
Dig Dis; 2009; 27(1):58-61. PubMed ID: 19439962
[TBL] [Abstract][Full Text] [Related]
33. [Long-term therapy of acid-dependent diseases with proton pump inhibitors and risk of colorectal cancer (literature review)].
Bordin DS; Masharova AA; Lazebnik LB
Eksp Klin Gastroenterol; 2008; (4):36-8. PubMed ID: 19145902
[No Abstract] [Full Text] [Related]
34. Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors.
Kothari S; Nelson SP; Wu EQ; Beaulieu N; McHale JM; Dabbous OH
Curr Med Res Opin; 2009 Nov; 25(11):2703-9. PubMed ID: 19775195
[TBL] [Abstract][Full Text] [Related]
35. Treatment patterns and symptom control in patients with GERD: US community-based survey.
Chey WD; Mody RR; Wu EQ; Chen L; Kothari S; Persson B; Beaulieu N; Lu M
Curr Med Res Opin; 2009 Aug; 25(8):1869-78. PubMed ID: 19530980
[TBL] [Abstract][Full Text] [Related]
36. A case of gastric polyposis in antral area of stomach following prolonged proton-pump therapy.
Alqutub AN; Masoodi I
Ger Med Sci; 2010 Sep; 8():. PubMed ID: 20930929
[TBL] [Abstract][Full Text] [Related]
37. Proton pump inhibitors for dyspepsia.
Vakil N
Dig Dis; 2008; 26(3):215-7. PubMed ID: 18463438
[TBL] [Abstract][Full Text] [Related]
38. Proton Pump Inhibitor Associated Multiple Gastric Hyperplastic Polyps With Uncontrollable Bleeding: A Case Report.
Nakashima M; Naoe H; Komohara Y; Waki K; Miyamoto H; Sakai Y; Kojima T; Kanemitsu T; Yao K; Tanaka Y
In Vivo; 2024; 38(3):1465-1469. PubMed ID: 38688629
[TBL] [Abstract][Full Text] [Related]
39. Nocturnal gastroesophageal reflux disease: issues, implications, and management strategies.
Johnson DA; Katz PO
Rev Gastroenterol Disord; 2008; 8(2):98-108. PubMed ID: 18641592
[TBL] [Abstract][Full Text] [Related]
40. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
